Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Biopsychosocial and clinical characteristics in patients with resected breast and colon cancer at the beginning and end of adjuvant treatment.

García-García T, Carmona-Bayonas A, Jimenez-Fonseca P, Jara C, Beato C, Castelo B, Mangas M, de Castro EM, Ramchandani A, Gomez D, Calderón C.

BMC Cancer. 2019 Nov 26;19(1):1143. doi: 10.1186/s12885-019-6358-x.

2.

Coping strategies and depressive symptoms in cancer patients.

Ghanem I, Castelo B, Jimenez-Fonseca P, Carmona-Bayonas A, Higuera O, Beato C, García T, Hernández R, Calderon C.

Clin Transl Oncol. 2019 May 10. doi: 10.1007/s12094-019-02123-w. [Epub ahead of print]

PMID:
31077086
3.

Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference centre in Spain.

Castelo B, Viñal D, Maseda R, Ostios L, Sánchez D, García-Salvatierra B, Escámez MJ, Martínez-Santamaría L, Del Río M, Mora-Rillo M, Vilches Y, Beato MJ, López Gutiérrez JC, Romero N, Santos C, Miranda J, de Lucas R.

Clin Transl Oncol. 2019 Nov;21(11):1573-1577. doi: 10.1007/s12094-019-02073-3. Epub 2019 Mar 12.

PMID:
30864020
4.

Effects of pessimism, depression, fatigue, and pain on functional health-related quality of life in patients with resected non-advanced breast cancer.

Calderon C, Carmona-Bayonas A, Hernández R, Ghanem I, Castelo B, Martinez de Castro E, Ferreira E, Ciria L, Muñiz M, Jimenez-Fonseca P.

Breast. 2019 Apr;44:108-112. doi: 10.1016/j.breast.2019.01.012. Epub 2019 Feb 2.

PMID:
30735899
5.

Differences in coping strategies among young adults and the elderly with cancer.

Hernández R, Calderon C, Carmona-Bayonas A, Rodríguez Capote A, Jara C, Padilla Álvarez A, Gómez-Camacho MLN, Beato C, Castelo B, Majem M, Muñoz MDM, Ivars A, Mangas-Izquierdo M, Rogado-Revuelta J, Jimenez-Fonseca P.

Psychogeriatrics. 2019 Sep;19(5):426-434. doi: 10.1111/psyg.12420. Epub 2019 Feb 5.

PMID:
30723983
6.

Incidence of sleep problems and their mediating role on depression and anxious preoccupation in patients with resected, non-advanced cancer: data from NEOcoping study.

Calderon C, Carmona-Bayonas A, Hernandez R, Castelo B, Varma S, Donnay O, Gomez D, Jimenez-Fonseca P.

Clin Transl Oncol. 2019 Aug;21(8):1104-1107. doi: 10.1007/s12094-018-02018-2. Epub 2019 Feb 2.

PMID:
30712235
7.

Psychometric properties and factorial analysis of invariance of the Satisfaction with Life Scale (SWLS) in cancer patients.

Lorenzo-Seva U, Calderon C, Ferrando PJ, Del Mar Muñoz M, Beato C, Ghanem I, Castelo B, Carmona-Bayonas A, Hernández R, Jiménez-Fonseca P.

Qual Life Res. 2019 May;28(5):1255-1264. doi: 10.1007/s11136-019-02106-y. Epub 2019 Jan 14.

PMID:
30644028
8.

Psychometric properties of the Shared Decision-Making Questionnaire (SDM-Q-9) in oncology practice.

Calderon C, Jiménez-Fonseca P, Ferrando PJ, Jara C, Lorenzo-Seva U, Beato C, García-García T, Castelo B, Ramchandani A, Muñoz MM, Martínez de Castro E, Ghanem I, Mangas M, Carmona-Bayonas A.

Int J Clin Health Psychol. 2018 May-Aug;18(2):143-151. doi: 10.1016/j.ijchp.2017.12.001. Epub 2018 Feb 13.

9.

Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy.

Sánchez-Barroso L, Apellaniz-Ruiz M, Gutiérrez-Gutiérrez G, Santos M, Roldán-Romero JM, Curras M, Remacha L, Calsina B, Calvo I, Sereno M, Merino M, García-Donas J, Castelo B, Guerra E, Letón R, Montero-Conde C, Cascón A, Inglada-Pérez L, Robledo M, Rodríguez-Antona C.

Oncologist. 2019 Aug;24(8):e784-e792. doi: 10.1634/theoncologist.2018-0418. Epub 2018 Nov 23.

10.

Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related Genes.

Mendiola M, Redondo A, Heredia-Soto V, Herranz J, Berjón A, Hernández A, Miguel-Martín M, Crespo R, Barriuso J, Cruz P, Yébenes L, Peláez-García A, Castelo B, DE Molina AR, Feliu J, Hardisson D.

Anticancer Res. 2018 Sep;38(9):5393-5400. doi: 10.21873/anticanres.12869.

PMID:
30194194
11.

Prospective analysis of psychological differences between adult and elderly cancer patients during postoperative adjuvant chemotherapy.

Muñoz-Sánchez MM, Calderon C, Jimenez-Fonseca P, Soriano-Rodríguez MC, Jara C, García-García T, Beato C, Rogado J, Castelo B, Hernández R, Mangas-Izquierdo M, Carmona-Bayonas A.

Clin Transl Oncol. 2018 Dec;20(12):1604-1611. doi: 10.1007/s12094-018-1901-9. Epub 2018 Jun 4.

PMID:
29869041
12.

SEOM clinical guideline in nasopharynx cancer (2017).

Pastor M, Lopez Pousa A, Del Barco E, Perez Segura P, Astorga BG, Castelo B, Bonfill T, Martinez Trufero J, Grau JJ, Mesia R.

Clin Transl Oncol. 2018 Jan;20(1):84-88. doi: 10.1007/s12094-017-1777-0. Epub 2017 Nov 2.

13.

Thyroid Metastasis as First Manifestation of a Colon Adenocarcinoma With KRAS Mutation: Usefulness of 18F-FDG PET/CT.

Lecumberri B, López E, Coronado M, Rodado S, Castelo B.

Clin Nucl Med. 2017 Oct;42(10):795-797. doi: 10.1097/RLU.0000000000001776.

PMID:
28872477
14.

Validation of SDM-Q-Doc Questionnaire to measure shared decision-making physician's perspective in oncology practice.

Calderon C, Ferrando PJ, Carmona-Bayonas A, Lorenzo-Seva U, Jara C, Beato C, García T, Ramchandani A, Castelo B, Muñoz MM, Garcia S, Higuera O, Mangas-Izquierdo M, Jimenez-Fonseca P.

Clin Transl Oncol. 2017 Nov;19(11):1312-1319. doi: 10.1007/s12094-017-1671-9. Epub 2017 May 11.

15.

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).

Mañós M, Giralt J, Rueda A, Cabrera J, Martinez-Trufero J, Marruecos J, Lopez-Pousa A, Rodrigo JP, Castelo B, Martínez-Galán J, Arias F, Chaves M, Herranz JJ, Arrazubi V, Baste N, Castro A, Mesía R.

Oral Oncol. 2017 Jul;70:58-64. doi: 10.1016/j.oraloncology.2017.04.004. Epub 2017 Apr 17. Review.

16.

Targeted Sequencing Reveals Low-Frequency Variants in EPHA Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy.

Apellániz-Ruiz M, Tejero H, Inglada-Pérez L, Sánchez-Barroso L, Gutiérrez-Gutiérrez G, Calvo I, Castelo B, Redondo A, García-Donás J, Romero-Laorden N, Sereno M, Merino M, Currás-Freixes M, Montero-Conde C, Mancikova V, Åvall-Lundqvist E, Green H, Al-Shahrour F, Cascón A, Robledo M, Rodríguez-Antona C.

Clin Cancer Res. 2017 Mar 1;23(5):1227-1235. doi: 10.1158/1078-0432.CCR-16-0694. Epub 2016 Aug 31.

17.

Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel.

Mendiola M, Martínez-Marin V, Herranz J, Heredia V, Yébenes L, Zamora P, Castelo B, Pinto Á, Miguel M, Díaz E, Gámez A, Fresno JÁ, Ramírez de Molina A, Hardisson D, Espinosa E, Redondo A.

Oncotarget. 2016 Apr 26;7(17):24217-27. doi: 10.18632/oncotarget.8128.

18.

Merkel cell carcinoma: An algorithm for multidisciplinary management and decision-making.

Prieto I, Pérez de la Fuente T, Medina S, Castelo B, Sobrino B, Fortes JR, Esteban D, Cassinello F, Jover R, Rodríguez N.

Crit Rev Oncol Hematol. 2016 Feb;98:170-9. doi: 10.1016/j.critrevonc.2015.10.008. Epub 2015 Nov 10. Review.

PMID:
26597015
19.

Use of bevacizumab as a first-line treatment for metastatic breast cancer.

Manso L, Moreno F, Márquez R, Castelo B, Arcediano A, Arroyo M, Ballesteros AI, Calvo I, Echarri MJ, Enrech S, Gómez A, González Del Val R, López-Miranda E, Martín-Angulo M, Martínez-Jañez N, Olier C, Zamora P.

Curr Oncol. 2015 Apr;22(2):e51-60. doi: 10.3747/co.22.2210.

20.

Prolonged response to aflibercept in ovarian cancer relapse: a case report.

Redondo A, Castelo B, Pinto A, Zamora P, Espinosa E.

Tumori. 2015 Mar 20;101(1):e29-31. doi: 10.5301/tj.5000202.

PMID:
25702661
21.

Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer.

Redondo A, Martínez V, Zamora P, Castelo B, Pinto A, Cruz P, Higuera O, Mendiola M, Hardisson D, Espinosa E.

Onco Targets Ther. 2014 Nov 27;7:2175-81. doi: 10.2147/OTT.S70654. eCollection 2014.

22.

Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy.

Apellániz-Ruiz M, Lee MY, Sánchez-Barroso L, Gutiérrez-Gutiérrez G, Calvo I, García-Estévez L, Sereno M, García-Donás J, Castelo B, Guerra E, Leandro-García LJ, Cascón A, Johansson I, Robledo M, Ingelman-Sundberg M, Rodríguez-Antona C.

Clin Cancer Res. 2015 Jan 15;21(2):322-8. doi: 10.1158/1078-0432.CCR-14-1758. Epub 2014 Nov 14.

23.

Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target.

Casado E, Garcia VM, Sánchez JJ, Gómez Del Pulgar MT, Feliu J, Maurel J, Castelo B, Moreno Rubio J, López RA, García-Cabezas MÁ, Burgos E, de Castro J, Belda-Iniesta C, López-Gómez M, Gómez-Raposo C, Zambrana F, Sereno M, Fernández-Martos C, Vázquez P, Lacal JC, González-Barón M, Cejas P.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1151-8. doi: 10.1016/j.ijrobp.2012.01.083. Epub 2012 Apr 18.

PMID:
22516806
24.

Targeting the endothelin axis in prostate carcinoma.

Pinto A, Merino M, Zamora P, Redondo A, Castelo B, Espinosa E.

Tumour Biol. 2012 Apr;33(2):421-6. doi: 10.1007/s13277-011-0299-6. Epub 2011 Dec 29. Review.

PMID:
22203496
25.

A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer.

Casado E, García VM, Sánchez JJ, Blanco M, Maurel J, Feliu J, Fernández-Martos C, de Castro J, Castelo B, Belda-Iniesta C, Sereno M, Sánchez-Llamas B, Burgos E, García-Cabezas MÁ, Manceñido N, Miquel R, García-Olmo D, González-Barón M, Cejas P.

Clin Cancer Res. 2011 Jun 15;17(12):4145-54. doi: 10.1158/1078-0432.CCR-10-2257. Epub 2011 Apr 5.

26.

Angiogenesis as a therapeutic target in urothelial carcinoma.

Pinto A, Redondo A, Zamora P, Castelo B, Espinosa E.

Anticancer Drugs. 2010 Nov;21(10):890-6. doi: 10.1097/CAD.0b013e32833e83b2. Review.

PMID:
20729712
27.

Combined therapy versus usual care for the treatment of depression in oncologic patients: a randomized controlled trial.

Rodríguez Vega B, Palao A, Torres G, Hospital A, Benito G, Pérez E, Dieguez M, Castelo B, Bayón C.

Psychooncology. 2011 Sep;20(9):943-52. doi: 10.1002/pon.1800. Epub 2010 Aug 4.

PMID:
20687194
28.

Clinical role of Sm-153 EDTMP in the treatment of painful bone metastatic disease.

Coronado M, Redondo A, Coya J, Espinosa E, Couto RM, Zamora P, Marin MD, Castelo B, Lillo ME, Frutos L, Barón MG, Curto LM.

Clin Nucl Med. 2006 Oct;31(10):605-10.

PMID:
16985364
29.

Re: Folliculitis associated with weekly paclitaxel treatment.

Belda-Iniesta C, Casado E, Corral de la Calle M, Castelo B, Barón MG.

J Natl Cancer Inst. 2003 Mar 5;95(5):410. No abstract available.

PMID:
12618506

Supplemental Content

Loading ...
Support Center